Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Isolated human mesenchymal stem cell expressing a bispecific antibody that binds CD33 and CD3 and method of using to treat cancer

Isolated human mesenchymal stem cell expressing a bispecific antibody that binds CD33 and CD3 and method of using to treat cancer

US Patent 10941202 · Granted Mar 9, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Targeting modules for universal chimeric antigen receptor expressing immune cell2024
Targeting modules for universal chimeric antigen receptor expressing immune cell2023
Universal chimeric antigen expressing immune cells for targeting of diverse mult2020
Universal chimeric antigen expressing immune cells for targeting of diverse mult2020
Isolated human mesenchymal stem cell expressing a bispecific antibody that binds2018